FibroBiologics (FibroBiologics) Total Liabilities : $15.26 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Total Liabilities?

FibroBiologics's Total Liabilities for the quarter that ended in Mar. 2024 was $15.26 Mil.

FibroBiologics's quarterly Total Liabilities increased from Sep. 2023 ($2.76 Mil) to Dec. 2023 ($10.57 Mil) and increased from Dec. 2023 ($10.57 Mil) to Mar. 2024 ($15.26 Mil).

FibroBiologics's annual Total Liabilities increased from Dec. 2021 ($1.76 Mil) to Dec. 2022 ($8.82 Mil) and increased from Dec. 2022 ($8.82 Mil) to Dec. 2023 ($10.57 Mil).

FibroBiologics Total Liabilities Historical Data

The historical data trend for FibroBiologics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Total Liabilities Chart

FibroBiologics Annual Data

Trend

Dec21

Dec22

Dec23

Total Liabilities

1.76

8.82

10.57

FibroBiologics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial				-	2.49	2.76	10.57	15.26

FibroBiologics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

FibroBiologics's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.183	+	(1.385	+	-2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10.57

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	11.821	-	1.253
	=	10.57

FibroBiologics's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	13.985	+	(1.277	+	1.1102230246252E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	15.26

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	11.399	-	-3.863
	=	15.26

FibroBiologics Total Liabilities Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics (FibroBiologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SG0:Germany

Address

455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598

Website

https://www.fibrobiologics.com

FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines

From GuruFocus

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

By PRNewswire • 02-12-2024

FibroBiologics Announces Three United States Patents for Fibroblast Technology

By PRNewswire • 02-12-2024